Pre-pandemic blood donors (BD; n = 106) and patients with autoimmune polyendocrine syndrome type 1 (APS1; AIRE mutation-positive—high levels of type I IFN autoantibodies) were respectively included as the negative and positive control groups12. The gene discussed is AIRE; the disease is autoimmune polyendocrine syndrome type 1.